4
Changes in Ownership
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-26-070248
Chairman, CEO and Interim CFO sold 4,126 shares at an average $3.18 ($13,110)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Pham Quang X · Chairman, CEO and Interim CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-16 | Sale : show line 1 in the form 10b5-1 | −3,613 | $3.18 | $11,489 | 129,102 | D |
| 2026-06-17 | Sale : show line 2 in the form 10b5-1 | −513 | $3.16 | $1,621 | 128,589 | D |
| Open-market sales · 4,126 sh · avg $3.18 · $13,110 | ||||||
Loading xslF345X06/ownership.xml…